Exacerbation of experimental autoimmune encephalomyelitis in mice deficient for DCIR, an inhibitory C-type lectin

Experimental Animals
|July 16, 2015
PubMed

Insights

Mice lacking dendritic cell immunoreceptor (DCIR) show worsened experimental autoimmune encephalomyelitis (EAE), a multiple sclerosis model. This suggests DCIR is crucial for regulating immune responses and preventing autoimmune diseases.

Area of Science:

  • Immunology
  • Neuroscience
  • Autoimmunity

Background:

  • Dendritic cell immunoreceptor (DCIR) is a C-type lectin receptor involved in immune regulation.
  • Previous studies indicated DCIR deficiency leads to autoimmune diseases due to dendritic cell expansion.

Purpose of the Study:

  • To investigate the role of DCIR in experimental autoimmune encephalomyelitis (EAE), a model for multiple sclerosis.
  • To understand DCIR's function in regulating immune responses during autoimmune neuroinflammation.

Main Methods:

  • Utilized Dcir knockout (Dcir-/-) mice and wild-type littermates.
  • Induced experimental autoimmune encephalomyelitis (EAE) in these mice.
  • Analyzed spinal cord pathology, immune cell infiltration (CD11c+ DCs, CD4+ T cells), and lymph node cell proliferation.

Main Results:

  • EAE severity was significantly increased in Dcir-/- mice compared to wild-type.
  • Dcir-/- mice exhibited severe demyelination in spinal cords.
  • Increased infiltration of dendritic cells and CD4+ T cells was observed in the spinal cords of Dcir-/- mice.
  • Lymph node cells from Dcir-/- mice showed a higher recall proliferative response.

Conclusions:

  • DCIR acts as a critical negative regulator of the immune system.
  • Loss of DCIR exacerbates autoimmune neuroinflammation, as evidenced by worsened EAE.
  • Dcir-/- mice serve as a valuable model for studying DCIR's role in various autoimmune diseases.

Related Concept Videos